Company Financials

Rhythm Pharmaceuticals, Inc. Financials

United States dollar

business Rhythm Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: RYTM

Market Capitalization $7.01 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -24.20
Forward PE -40.14
Price to Sales TTM $40.20
Price to Book MRQ $47.05
Enterprise to Revenue 39.30
Enterprise to EBITDA -37.09

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin -110.32%
Operating Margin -102.64%
Return on Assets TTM -26.74%
Return on Equity TTM -85.79%

Income Statement

Revenue TTM $174,334,000
Revenue per Share TTM $2.74
Quarterly Revenue Growth 54.30%
Gross Profit TTM $155,856,992
EBITDA $-184,759,008
Net Income to Common TTM $-197,711,008
Diluted EPS TTM $-3.10
Quarterly Earnings Growth YoY 54.28%

Balance Sheet

Total Cash MRQ $416,052,000
Total Cash per Share MRQ $6.23
Total Debt MRQ $
Total Debt to Equity MRQ 38.25
Current Ratio MRQ 4.75
Book Value per Share MRQ $2.23

Cash Flow

Operating Cash Flow TTM $-109,131,000
Levered Free Cash Flow TTM $-146,524,368

RYTM Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 66,684,077
Float Shares 54,999,853
Avg 10 Volume 671,418
Avg 30 Volume None
Shares Short 5,581,124
Short Ratio 6.06
Short % of Shares 10.71%
% Held by Insiders 0.64%
% Held by Institutions 109.16%

Stock Price Summary

Beta 1.97
Fifty Two Week Low $45.91
Fifty Two Week High $122.20
Fifty Two Week Change 43.84%
Day 50 MA $106.89
Day 200 MA $85.31

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date